Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Active U.S. Real Estate Powershares | PSR | Apr 26, 2024 | 81.18 | +0.04 |
Acuity Brands | AYI | Apr 26, 2024 | 252.16 | +0.17 |
Acumen Pharmaceuticals | ABOS | Apr 26, 2024 | 3.17 | -0.63 |
Acurx Pharmaceuticals | ACXP | Apr 26, 2024 | 2.07 | +2.48 |
Acushnet | GOLF | Apr 26, 2024 | 62.23 | +1.07 |
Acutus Medical | AFIB | Apr 26, 2024 | 0.17 | +1.90 |
ACV Auctions A | ACVA | Apr 26, 2024 | 18.09 | +2.09 |
ACWI Ex-US Index MSCI Ishares | ACWX | Apr 26, 2024 | 52.53 | +0.79 |
ACWI Index MSCI Ishares | ACWI | Apr 26, 2024 | 107.38 | +0.93 |
Adagene ADR | ADAG | Apr 26, 2024 | 2.39 | +1.70 |
Adamas One | JEWL | Apr 26, 2024 | 0.31 | -0.29 |
Adams Diversified Equity Fund | ADX | Apr 26, 2024 | 18.98 | +1.39 |
Adams Natural Resources Fund | PEO | Apr 26, 2024 | 23.42 | -0.89 |
Adams Resources & Energy | AE | Apr 26, 2024 | 29.85 | +2.23 |
AdaptHealth | AHCO | Apr 26, 2024 | 9.96 | +3.97 |
Adaptimmune Therapeutics ADR | ADAP | Apr 26, 2024 | 1.08 | +1.42 |
Adaptive Biotechnologies | ADPT | Apr 26, 2024 | 2.60 | -0.38 |
ADC Therapeutics SA | ADCT | Apr 26, 2024 | 4.34 | -2.25 |
Addentax Group | ATXG | Apr 26, 2024 | 0.94 | +1.40 |
Addex Therapeutics ADR | ADXN | Apr 26, 2024 | 16.10 | +4.48 |
Addus HomeCare | ADUS | Apr 26, 2024 | 94.54 | +3.10 |
Adecoagro | AGRO | Apr 26, 2024 | 11.05 | +0.73 |
Adeia | ADEA | Apr 26, 2024 | 10.14 | -0.15 |
Adial Pharmaceuticals | ADIL | Apr 26, 2024 | 1.61 | -6.94 |
Adicet Bio | ACET | Apr 26, 2024 | 1.68 | -7.18 |
Adient | ADNT | Apr 26, 2024 | 30.42 | +3.43 |
Aditxt | ADTX | Apr 26, 2024 | 2.39 | -5.53 |
Adlai Nortye | ANL | Apr 26, 2024 | 13.75 | +2.15 |
ADMA Biologics | ADMA | Apr 26, 2024 | 6.55 | +1.71 |
Adobe | ADBE | Apr 26, 2024 | 477.56 | +0.87 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.